On 1 May the Centre for Science and Policy hosted a workshop in association with the Centre for Law Medicine and Life Sciences at the University of Cambridge. The overall aim was to identify and discuss key issues in intellectual property (IP) policies and strategies affecting the development of genomic medicine.